Clinical trials
Recruiting Hyperlipidemias trials in the United States
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
22 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2021 | 1 |
| 2022 | 1 |
| 2023 | 1 |
| 2024 | 8 |
| 2025 | 9 |
| 2026 | 2 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Recruiting | 22 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Novartis Pharmaceuticals | 2 |
| University of Alabama at Birmingham | 2 |
| Arrowhead Pharmaceuticals | 1 |
| Cambridge Health Alliance | 1 |
| Colorado Prevention Center | 1 |
| Esperion Therapeutics, Inc. | 1 |
| Johns Hopkins University | 1 |
| Ohio State University | 1 |
| Purdue University | 1 |
| Rush University Medical Center | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Hyperlipidemias | 22 |
| Hypertension | 9 |
| Hypercholesterolemia | 8 |
| Diabetes Mellitus | 7 |
| Cardiovascular Diseases | 6 |
| Obesity | 5 |
| Heart Failure | 4 |
| Hyperlipoproteinemia Type II | 4 |
| Diabetes Mellitus, Type 2 | 3 |
| Dyslipidemias | 3 |
Trials
Showing 1 to 22 of 22. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.